SCHEMBL3170639

SCHEMBL3170639

CC(=O)NCCNc1cc(NCCNC(=O)Cc2ccccc2)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
HPGD P15428 3/20 0.48
MEN1 O00255 2/20 0.48
ALDH1A1 P00352 6/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
CYP1A2 P05177 3/20 0.46
CYP3A4 P08684 3/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
ADORA3 P0DMS8 3/20 0.46
NPY5R Q15761 1/20 0.45
CNR1 P21554 1/20 0.45
CNR2 P34972 1/20 0.45
ALOX15 P16050 2/20 0.44
HSD17B10 Q99714 2/20 0.44
TP53 P04637 2/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3169166 0.96 ALDH1A1 (0.49) KMT2AHPGDMEN1ALDH1A1SMN1; SMN2
SCHEMBL3156387 0.92 ADORA2A (0.48) HPGDALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL3164379 0.91 TP53 (0.52) KMT2AHPGDMEN1ALDH1A1SMN1; SMN2
SCHEMBL3162245 0.90 ALDH1A1 (0.47) KMT2AMEN1ALDH1A1CYP1A2CYP3A4
SCHEMBL3174225 0.90 TP53 (0.43) KMT2AHPGDMEN1ALDH1A1SMN1; SMN2
SCHEMBL3177073 0.90 CYP1A2 (0.47) KMT2AMEN1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL3176265 0.88 MEN1 (0.50) KMT2AMEN1SMN1; SMN2ADORA3CNR2
SCHEMBL3176983 0.88 ADORA3 (0.57) KMT2AMEN1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL3171330 0.87 CA1 (0.48) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2D6
SCHEMBL3171181 0.87 CYP1A2 (0.47) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed